News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | US-Iran Easing Remarks Boost Market; US Stocks, Crypto and Gold All Rebound; Nvidia Invests $2B in Marvell Technology (April 1, 2026)2Micron Drops 30% While Analysts Remain Optimistic3CoinShares' Historic Bitcoin Outflows Conceal a Strategic Buying Opportunity During Broader Market Turbulence
Oklo and Blykalla Partner to Speed Up the Advancement of Next-Generation Nuclear Power
101 finance·2026/04/01 14:25
AGH Soars on Merger — But Volume Tells a Different Story
101 finance·2026/04/01 14:24
BAC Options Alert: Subtle Bullish Pattern—Consider Trades at $50 as RSI Surpasses 50
101 finance·2026/04/01 14:24
FCL's Agreement with School District Sparks Widespread Safety Discussion—Will Growth Outpace Supply Limitations?
101 finance·2026/04/01 14:21
Hasbro Faces Price-Action Warning: Can It Outrun the Priced-In Bull Case?
101 finance·2026/04/01 14:21
Turning Point Brands Plunges 16% During the Day – What’s Behind the Steep Drop?
101 finance·2026/04/01 14:21
Strategy’s $80K Turning Point: Will Accumulation Prevail Against Options Headwinds?
101 finance·2026/04/01 14:21
East Side Games’ $4M Yearly Cost Reduction Sparks Strategic Undervaluation Opportunity
101 finance·2026/04/01 14:21
Flash
14:27
According to data from the Federal Reserve Bank of New York, the Secured Overnight Financing Rate (SOFR) was 3.68% on the last trading day (March 31, coinciding with month-end and quarter-end), compared to 3.63% the previous day.The effective federal funds rate for the previous trading day was reported at 3.64%, unchanged from 3.64% the day before.
14:26
Turning Point Brands Inc. (TPB) shares plummeted by 20% today after Reuters reported delays in the FDA approval process for its nicotine pouch products.This news has caused concern among investors, and the market is now questioning whether the company’s new product can be launched on schedule. The sharp decline in share price reflects the market’s negative response to the uncertainty surrounding regulatory approval.
14:26
Philip Morris shares suffered a sharp decline, with the intraday drop reaching 7%, marking the lowest level since January this year.The recent share price decline is closely linked to a market report. According to Reuters, the U.S. Food and Drug Administration (FDA) has significantly slowed the advancement of its fast-track approval process for nicotine pouch products. This news has cast doubt on the prospects of related products under Philip Morris, triggering investor sell-offs and putting downward pressure on the share price.
News